NOVEL CORONAVIRUS DISEASE (SARS-COV-2): AN OVERVIEW

Main Article Content

DIGVIJAY PANDEY
TAJAMUL ISLAM
MANSOOR A. MALIK

Abstract

The COVID-19 pandemic has brought about school terminations and removing necessities that have upset both work and day to day life for some. Concerns exist that these disturbances brought about by the pandemic might not have impacted people scientists similarly. The virus originated in bats and was transmitted to humans through yet unknown intermediary animals in Wuhan, Hubei province, China in December 2019. The symptoms are usually fever, cough, sore throat, breathlessness, fatigue, malaise among others. Treatment is essentially supportive; role of antiviral agents is yet to be established. Prevention entails home isolation of suspected cases and those with mild illnesses and strict infection control measures at hospitals that include contact and droplet precautions. The virus spreads faster than its two ancestors the SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), but has lower fatality. The global impact of this new epidemic is yet uncertain.

Keywords:
Coronavirus, pandemic, transmission, symptoms

Article Details

How to Cite
PANDEY, D., ISLAM, T., & MALIK, M. A. (2021). NOVEL CORONAVIRUS DISEASE (SARS-COV-2): AN OVERVIEW. Asian Journal of Advances in Medical Science, 3(2), 8-12. Retrieved from https://mbimph.com/index.php/AJOAIMS/article/view/1929
Section
Mini Review Article

References

Worldometer.

Available:www.worldometers.info

(Accessed on 20 January 2021)

Chan JW, Ng CK, Chan YH, Mok TY, Lee S, Chu SY, Law WL, Lee MP, Li PC. Short term outcome and risk factors for adverse clinical outcomes in adults with severe acute respiratory syndrome (SARS). Thorax. 2003;58:686–689.

DOI: 10.1136/thorax.58.8.686

Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2 [published online March 17, 2020]. Nat Med; 2020.

DOI: 10.1038/s41591-020-0820-9.

Available:https://www.nature.com/articles/s41591020-0820-9

Zhang T, Wu Q, Zhang Z. Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak [published online March 13, 2020]. Curr Biol; 2020.

DOI: 10.1016/j.cub.2020.03.022.

Available:https://www.sciencedirect.com/science/article/pii/S0960982220303602.

Murthy S, Gomersall CD, Fowler RA. Care for critically ill patients with COVID-19. JAMA; 2020.

Cao J, Hu X, Cheng W, Yu L, Tu W-J, Liu Q. Clinical features and short-term outcomes of 18 patients with corona virus disease 2019 in intensive care unit. Intensive Care Med. 2020;46:851.

Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;10022:1–8.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARSCoV-2 admitted to ICUs of the Lombardy region. Italy JAMA. 2020;24: 122.

Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. Lancet Respir Med. 2020;2600:1–7.

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA; 2020.

Slutsky AS, Ranieri VM. Ventilator-induced lung injury. N Engl J Med. 2013;369:2126–36.

Laffey JG, Bellani G, Pham T, Fan E, Madotto F, Bajwa EK, et al. Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study. Intensive Care Med. 2016;42: 1865–76.

Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506.

Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-513.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-847.

Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-1720.

Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-1062.

Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2 [published online March 17, 2020]. Nat Med; 2020.

DOI: 10.1038/s41591-020-0820-9.

Available:https://www.nature.com/articles/s41591020-0820-9

Tikellis C, Thomas MC. Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease. Int J Pept. 2012;2012:256294.

DOI: 10.1155/2012/256294

Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target [published online March 3, 2020]. Intensive Care Med; 2020.

DOI: 10.1007/s00134-020-05985-9.

Available:https://link.springer.com/ article/10.1007/s00134-020-05985-9.

Zou L, Ruan F, Huang M, Liang L, Huang H, Hong Z, Yu J, Kang M, Song Y, Xia J, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N Engl J Med. 2020;382:1177–1179.

DOI: 10.1056/NEJMc2001737

World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19); 2020.

Available:https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirusdisease-2019-(covid-19). Published 2020. Accessed February 28, 2020.

Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, Liu L, Shan H, Lei C-l, Hui DSC, et al. Clinical characteristics of coronavirus disease 2019 in China [published online February 28, 2020]. N Engl J Med; 2020.

DOI: 10.1056/NEJMoa2002032.

Available:https://www.nejm.org/doi/full/10.1056/NEJMoa2002032.

Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, Azman AS, Reich NG, Lessler J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application [published online March 10, 2020]. Ann Intern Med; 2020.

DOI: 10.7326/M20-0504.

Dowd KA, Ko SY, Morabito KM, Yang ES, Pelc RS, DeMaso CR, et al. Rapid development of a DNA vaccine for Zika virus. Science. 2016;354:237–240.

DOI:10.1126/science.aai9137 Medline

Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017; 543:248–251.

DOI: 10.1038/nature21428 Medline